Myriad Genetics Reports Second Quarter Financial Results
Highlights: Revenue of $179.3 million for the quarter ended June 30, 2022 Excluding revenue from divested…
Year: 2022
BioCryst Reports Second Quarter 2022 Financial Results and Upcoming Key Milestones
—Q2 2022 ORLADEYO net revenue of $65.2 million— —FY 2022 ORLADEYO net revenue expected to…
Societal CDMO Adds Three New Customers, Signing Agreements to Provide CDMO Services Supporting Clinical Development of Several Novel Therapeutic Candidates
Contracted Activities Touch Upon Broad Range of Societal’s Offerings from Clinical Trial Services to Formulation…
Agios Reports Business Highlights and Second Quarter 2022 Financial Results
– Generated $3.1 Million in Net U.S. Revenue for First Full Quarter of PYRUKYND® (mitapivat)…
Amicus Therapeutics Announces Second Quarter 2022 Financial Results
1H22 Galafold® Revenue of $159.4M, reflecting 11% Sales Growth with Operational Growth of 18%, Partly Offset…
RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMO
RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMO Combination creates global…
Walden Biosciences Announces Presentation at Canaccord Genuity 42nd Annual Growth Conference
Presentation to highlight transformational approach to treating kidney diseases CAMBRIDGE, Mass., Aug. 04, 2022 (GLOBE…
Breckenridge Distillery and Denver Broncos Release Limited-Edition Mile High Bourbon Blends
America’s Best Blended Whiskey is Back and Better Than Ever Breckenridge x Denver Broncos Mile…
Arvinas Reports Second Quarter 2022 Financial Results and Provides Corporate Update
NEW HAVEN, Conn., Aug. 04, 2022 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage…
COMPASS Pathways plc announces second quarter 2022 financial results and business highlights
LONDON, Aug. 04, 2022 (GLOBE NEWSWIRE) — Highlights: Kabir Nath appointed as Chief Executive Officer…
HOOKIPA Pharma to Report Second Quarter 2022 Financial Results on August 11, 2022
NEW YORK and VIENNA, Austria, Aug. 04, 2022 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ:…
ProQR Announces Second Quarter 2022 Operating and Financial Results
ProQR is accelerating the development of its Axiomer® RNA base-editing technology platform across multiple therapeutic…
iSpecimen Reports Second Quarter 2022 Financial and Operating Results
Enhanced iSpecimen Marketplace® Platform with Data Integration Capabilities to Simplify the Ingestion and Maintenance of…
Orchard Therapeutics Reports Second Quarter 2022 Financial Results and Reviews Recent Business Highlights
Additional Libmeldy® reimbursement discussions advancing across Europe with product sales totaling $3.1M in Q2 and…
Travere Therapeutics Reports Second Quarter 2022 Financial Results
SAN DIEGO, Aug. 04, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported…
XORTX Announces Pre-Phase 3 Meeting Date with US Food and Drug Administration
Pre-Phase 3 Meeting Briefing Package Filed CALGARY, Alberta, Aug. 04, 2022 (GLOBE NEWSWIRE) — XORTX…
Verizon awarded most reliable 5G network for the third time in a row
NEW YORK, Aug. 04, 2022 (GLOBE NEWSWIRE) — Verizon remains the standard for network reliability,…
AvePoint EduTech Rebrands to MaivenPoint to Focus on the Future of Learning
SaaS modern learning product line expands digital expertise and global reach with new acquisitions, accolades…
PRESS RELEASE: SSH’s Tectia Quantum-Safe Edition uses a NIST-selected algorithm
The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has chosen the first…
TRON Grand Hackathon Season 2 Closes out Submission with over 1800 Participants
Geneva, Switzerland–(Newsfile Corp. – August 4, 2022) – Season 2 of The TRON Grand Hackathon…